Methods to increase antigenicity of membrane-bound polypeptides produced in plants
Increased antigenicity of a membrane-bound polypeptide produced from a plant is provided in a process in which extraction of the polypeptide or other compounds from the plant is such that phospholipids are associated with the polypeptide. Reducing fat by supercritical fluid extraction increases antigenicity of such plant-produced membrane-bound polypeptides. Methods and means of producing such membrane-bound polypeptides are provided. Methods to produce a protective response in animals are provided by administering to the animal the membrane-bound polypeptide. Binding of antibody specific to the membrane-bound polypeptide is increased. The process provides for increased preferred formation of the membrane-bound polypeptide. Stability of the membrane-bound polypeptide is increased when the plant material is defatted.
1. A method of increasing an immune response in an animal to a plant-produced hepatitis B membrane-bound polypeptide, the method comprising,
a) introducing a hepatitis B surface antigen (HBsAg) membrane-bound polypeptide in a plant, plant part, plant tissue or plant cell;
b) extracting lipids from germ or seed or both by a process that extract more nonpolar lipids than phospholipids and removes a lower amount of phospholipids than hexane extraction to produce a plant composition comprising said germ or seed or both, wherein said germ or seed or both comprises said HBsAg, and wherein said process comprises supercritical fluid extraction;
c) administering said plant composition having said lipids extracted comprising said membrane-bound polypeptide to an animal; and
producing an increased immune response in said animal to said HBsAg membrane-bound polypeptide compared to immune response when administering to said animal said plant-produced membrane-bound polypeptide wherein lipids are extracted from a plant, plant part, plant tissue or collection of plant cells comprising said hepatitis B membrane-bound polypeptide by a process that does not extract more nonpolar lipids than phospholipids and a lower amount of phospholipids than hexane extraction.
2. The method of claim 1 , wherein said membrane-bound polypeptide is administered to said animal and increases said immune response by at least 25%.
3. The method of claim 1 , wherein said plant composition is orally administered to said animal.
4. The method of claim 1 , wherein said plant composition comprises flour and further comprising orally administering said flour to said animal.
5. The method of claim 3 , wherein said membrane-bound polypeptide is administered to said animal and said immune response comprises production of mucosal antibodies, production of serum antibodies or both.
6. The method of claim 3 , wherein said oral administration is a booster administration.
7. The method of claim 1 , wherein said process removes at least two fold lower amount of phospholipids than hexane extraction.
8. The method of claim 1 , wherein said process removes at least ten fold lower amount of phospholipids than hexane extraction.
9. The method of claim 1 , wherein said plant, plant part, plant tissue or plant cell comprises maize.
10. The method of claim 1 , wherein said plant, plant part, plant tissue or plant cell comprises a monocotyledonous plant, plant part, plant tissue or plant cell.
11. The method of claim 1 , further comprising after extracting said lipids, determining if said membrane-bound polypeptide has a higher amount of said membrane-bound polypeptide in a preferred formation than in non-preferred formation; and
selecting said membrane-bound polypeptide where there is a higher amount of membrane-bound polypeptide in said preferred formation.
12. The method of claim 1 , wherein and said plant, plant part, plant tissue or plant cell comprises maize.
13. A method of increasing an immune response of a plant-produced membrane-bound polypeptide, said method comprising,
a) introducing a hepatitis B surface antigen (HBsAg) membrane-bound polypeptide in a plant, plant part, plant tissue or plant cell;
b) reducing lipid content in germ or seed or both by supercritical fluid extraction to produce a plant composition comprising said germ or seed or both, wherein said germ or seed or both comprises said HBsAg; and
c) providing said plant composition comprising said HBsAg membrane-bound polypeptide in an orally acceptable composition such that said polypeptide produces an increased immune response when administered to an animal, compared to said membrane-bound polypeptide produced in a plant composition in which lipid content is reduced by hexane extraction.